| Jacob Robinson, DPT | |
|
2556 Eastern Blvd Ste 15, York, PA 17402-2914 | |
| (717) 900-1743 | |
| Not Available |
| Full Name | Jacob Robinson |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 5 Years |
| Location | 2556 Eastern Blvd Ste 15, York, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063045474 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT027913 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Drayer Physical Therapy Institute Llc | 8224948666 | 202 |
News Archive
South Korea has opened a bank in Seoul that will create and supply new lines of embryonic stem cells for research around the world.
A new study in people with major depression reports that electroconvulsive therapy induces changes in the fibers connecting the hippocampus to brain regions involved in mood and emotion.
Not enough communication takes place between drug companies and payers before Phase 3, according to a new study from Cutting Edge Information (http://www.cuttingedgeinfo.com/market-access/). The study finds that drug companies contact payers an average 2.4 times in all of Phase 2.
Mirna Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering microRNA-based Replacement Therapy to treat cancer, today announced the enrollment of the first patient in the hematological malignancy cohort of its ongoing Phase 1 clinical trial of MRX34, the company's lead product candidate and first microRNA mimic in human clinical trials in oncology.
John S. Kovach, M.D., Chair, Board of Directors and CEO of Lixte Biotechnology Holdings, Inc., announces that the United States Patent and Trademark Office awarded a patent on its lead compound, LB-100, as well as a number of structurally related compounds, which has shown promising anti-cancer activity.
› Verified 6 days ago
| Provider Name | Drayer Physical Therapy Institute Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1538122700 PECOS PAC ID: 8224948666 Enrollment ID: O20040126000110 |
News Archive
South Korea has opened a bank in Seoul that will create and supply new lines of embryonic stem cells for research around the world.
A new study in people with major depression reports that electroconvulsive therapy induces changes in the fibers connecting the hippocampus to brain regions involved in mood and emotion.
Not enough communication takes place between drug companies and payers before Phase 3, according to a new study from Cutting Edge Information (http://www.cuttingedgeinfo.com/market-access/). The study finds that drug companies contact payers an average 2.4 times in all of Phase 2.
Mirna Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering microRNA-based Replacement Therapy to treat cancer, today announced the enrollment of the first patient in the hematological malignancy cohort of its ongoing Phase 1 clinical trial of MRX34, the company's lead product candidate and first microRNA mimic in human clinical trials in oncology.
John S. Kovach, M.D., Chair, Board of Directors and CEO of Lixte Biotechnology Holdings, Inc., announces that the United States Patent and Trademark Office awarded a patent on its lead compound, LB-100, as well as a number of structurally related compounds, which has shown promising anti-cancer activity.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jacob Robinson, DPT 1200 Corporate Dr Ste 400, Birmingham, AL 35242-5424 Ph: () - | Jacob Robinson, DPT 2556 Eastern Blvd Ste 15, York, PA 17402-2914 Ph: (717) 900-1743 |
News Archive
South Korea has opened a bank in Seoul that will create and supply new lines of embryonic stem cells for research around the world.
A new study in people with major depression reports that electroconvulsive therapy induces changes in the fibers connecting the hippocampus to brain regions involved in mood and emotion.
Not enough communication takes place between drug companies and payers before Phase 3, according to a new study from Cutting Edge Information (http://www.cuttingedgeinfo.com/market-access/). The study finds that drug companies contact payers an average 2.4 times in all of Phase 2.
Mirna Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering microRNA-based Replacement Therapy to treat cancer, today announced the enrollment of the first patient in the hematological malignancy cohort of its ongoing Phase 1 clinical trial of MRX34, the company's lead product candidate and first microRNA mimic in human clinical trials in oncology.
John S. Kovach, M.D., Chair, Board of Directors and CEO of Lixte Biotechnology Holdings, Inc., announces that the United States Patent and Trademark Office awarded a patent on its lead compound, LB-100, as well as a number of structurally related compounds, which has shown promising anti-cancer activity.
› Verified 6 days ago
Theresa C Rill, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2760 Pine Grove Rd, York, PA 17403 Phone: 717-741-1250 | |
Rosemary T Prego, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1665 Roosevelt Ave, York, PA 17408 Phone: 717-848-4800 | |
Mrs. Laura W Byrne, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1410 E Market St, York, PA 17403 Phone: 717-846-8455 Fax: 717-846-0562 | |
Mrs. Sandra A Daw, M.S.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1855 Powder Mill Rd, York, PA 17402 Phone: 717-848-4800 Fax: 717-718-3150 | |
Diane Marilyn Zimardo, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1575 Bannister St Ste 4, York, PA 17404 Phone: 717-812-5850 | |
Mr. David Michael Heiland, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1855 Powder Mill Rd, York, PA 17402 Phone: 717-848-4800 Fax: 717-741-4240 | |
Drayer Physical Therapy Institute Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1805 Loucks Rd, Suite 200, York, PA 17408 Phone: 717-764-0144 Fax: 717-764-0554 |